Logo image of PBI

PITNEY BOWES INC (PBI) Stock Fundamental Analysis

NYSE:PBI - New York Stock Exchange, Inc. - US7244791007 - Common Stock - Currency: USD

10.28  -0.21 (-2%)

After market: 10.25 -0.03 (-0.29%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PBI. PBI was compared to 83 industry peers in the Commercial Services & Supplies industry. There are concerns on the financial health of PBI while its profitability can be described as average. PBI is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PBI was profitable.
In the past year PBI had a positive cash flow from operations.
PBI had negative earnings in 4 of the past 5 years.
PBI had a positive operating cash flow in each of the past 5 years.
PBI Yearly Net Income VS EBIT VS OCF VS FCFPBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

PBI's Return On Assets of -5.14% is on the low side compared to the rest of the industry. PBI is outperformed by 68.67% of its industry peers.
With a decent Return On Invested Capital value of 9.67%, PBI is doing good in the industry, outperforming 72.29% of the companies in the same industry.
PBI had an Average Return On Invested Capital over the past 3 years of 7.15%. This is below the industry average of 11.67%.
The 3 year average ROIC (7.15%) for PBI is below the current ROIC(9.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -5.14%
ROE N/A
ROIC 9.67%
ROA(3y)-4.75%
ROA(5y)-3.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.15%
ROIC(5y)5.48%
PBI Yearly ROA, ROE, ROICPBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

With a decent Operating Margin value of 8.65%, PBI is doing good in the industry, outperforming 63.86% of the companies in the same industry.
PBI's Operating Margin has improved in the last couple of years.
PBI's Gross Margin of 52.83% is amongst the best of the industry. PBI outperforms 91.57% of its industry peers.
In the last couple of years the Gross Margin of PBI has grown nicely.
Industry RankSector Rank
OM 8.65%
PM (TTM) N/A
GM 52.83%
OM growth 3Y37.5%
OM growth 5Y3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.73%
GM growth 5Y5.55%
PBI Yearly Profit, Operating, Gross MarginsPBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PBI is destroying value.
The number of shares outstanding for PBI has been increased compared to 1 year ago.
Compared to 5 years ago, PBI has more shares outstanding
Compared to 1 year ago, PBI has a worse debt to assets ratio.
PBI Yearly Shares OutstandingPBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
PBI Yearly Total Debt VS Total AssetsPBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

PBI has an Altman-Z score of 2.31. This is not the best score and indicates that PBI is in the grey zone with still only limited risk for bankruptcy at the moment.
PBI's Altman-Z score of 2.31 is in line compared to the rest of the industry. PBI outperforms 49.40% of its industry peers.
PBI has a debt to FCF ratio of 12.62. This is a negative value and a sign of low solvency as PBI would need 12.62 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.62, PBI perfoms like the industry average, outperforming 51.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.62
Altman-Z 2.31
ROIC/WACC0.92
WACC10.51%
PBI Yearly LT Debt VS Equity VS FCFPBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.80 indicates that PBI may have some problems paying its short term obligations.
The Current ratio of PBI (0.80) is worse than 86.75% of its industry peers.
A Quick Ratio of 0.75 indicates that PBI may have some problems paying its short term obligations.
PBI has a worse Quick ratio (0.75) than 81.93% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.75
PBI Yearly Current Assets VS Current LiabilitesPBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2125.00% over the past year.
Measured over the past years, PBI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.76% on average per year.
PBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.75%.
The Revenue has been decreasing by -8.76% on average over the past years.
EPS 1Y (TTM)2125%
EPS 3Y19.79%
EPS 5Y-5.76%
EPS Q2Q%3400%
Revenue 1Y (TTM)-22.75%
Revenue growth 3Y-17.98%
Revenue growth 5Y-8.76%
Sales Q2Q%-40.59%

3.2 Future

Based on estimates for the next years, PBI will show a very strong growth in Earnings Per Share. The EPS will grow by 53.91% on average per year.
Based on estimates for the next years, PBI will show a very negative growth in Revenue. The Revenue will decrease by -12.41% on average per year.
EPS Next Y128.63%
EPS Next 2Y53.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-23.59%
Revenue Next 2Y-12.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PBI Yearly Revenue VS EstimatesPBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
PBI Yearly EPS VS EstimatesPBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.55, the valuation of PBI can be described as very reasonable.
PBI's Price/Earnings ratio is rather cheap when compared to the industry. PBI is cheaper than 84.34% of the companies in the same industry.
PBI is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 7.89 indicates a rather cheap valuation of PBI.
Based on the Price/Forward Earnings ratio, PBI is valued cheaper than 93.98% of the companies in the same industry.
PBI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 11.55
Fwd PE 7.89
PBI Price Earnings VS Forward Price EarningsPBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PBI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PBI is cheaper than 63.86% of the companies in the same industry.
80.72% of the companies in the same industry are more expensive than PBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.97
EV/EBITDA 10.85
PBI Per share dataPBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PBI's earnings are expected to grow with 53.91% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y53.91%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.67%, PBI has a reasonable but not impressive dividend return.
PBI's Dividend Yield is rather good when compared to the industry average which is at 2.57. PBI pays more dividend than 86.75% of the companies in the same industry.
PBI's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.67%

5.2 History

The dividend of PBI has a limited annual growth rate of 0.29%.
PBI has paid a dividend for at least 10 years, which is a reliable track record.
As PBI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.29%
Div Incr Years0
Div Non Decr Years5
PBI Yearly Dividends per sharePBI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of PBI are negative and hence is the payout ratio. PBI will probably not be able to sustain this dividend level.
The dividend of PBI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-22.66%
EPS Next 2Y53.91%
EPS Next 3YN/A
PBI Yearly Income VS Free CF VS DividendPBI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

PITNEY BOWES INC

NYSE:PBI (6/13/2025, 8:04:00 PM)

After market: 10.25 -0.03 (-0.29%)

10.28

-0.21 (-2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners71.67%
Inst Owner Change0.11%
Ins Owners0.53%
Ins Owner Change3.17%
Market Cap1.86B
Analysts45
Price Target17.34 (68.68%)
Short Float %6.85%
Short Ratio5.66
Dividend
Industry RankSector Rank
Dividend Yield 2.67%
Yearly Dividend0.2
Dividend Growth(5Y)0.29%
DP-22.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date05-19 2025-05-19 (0.07)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.76%
Min EPS beat(2)21.01%
Max EPS beat(2)118.51%
EPS beat(4)4
Avg EPS beat(4)82.62%
Min EPS beat(4)21.01%
Max EPS beat(4)142.43%
EPS beat(8)7
Avg EPS beat(8)82.12%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.88%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-9.26%
Min Revenue beat(4)-37.19%
Max Revenue beat(4)1.77%
Revenue beat(8)5
Avg Revenue beat(8)-4.51%
Revenue beat(12)5
Avg Revenue beat(12)-4.57%
Revenue beat(16)6
Avg Revenue beat(16)-3.66%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)4.18%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 11.55
Fwd PE 7.89
P/S 0.74
P/FCF 11.97
P/OCF 8.28
P/B N/A
P/tB N/A
EV/EBITDA 10.85
EPS(TTM)0.89
EY8.66%
EPS(NY)1.3
Fwd EY12.67%
FCF(TTM)0.86
FCFY8.36%
OCF(TTM)1.24
OCFY12.08%
SpS13.9
BVpS-2.96
TBVpS-7.08
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.14%
ROE N/A
ROCE 12.24%
ROIC 9.67%
ROICexc 11.95%
ROICexgc 24.84%
OM 8.65%
PM (TTM) N/A
GM 52.83%
FCFM 6.18%
ROA(3y)-4.75%
ROA(5y)-3.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.15%
ROIC(5y)5.48%
ROICexc(3y)9.55%
ROICexc(5y)7.35%
ROICexgc(3y)19.63%
ROICexgc(5y)15.21%
ROCE(3y)9.05%
ROCE(5y)6.94%
ROICexcg growth 3Y51.48%
ROICexcg growth 5Y14.95%
ROICexc growth 3Y42.21%
ROICexc growth 5Y11.6%
OM growth 3Y37.5%
OM growth 5Y3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.73%
GM growth 5Y5.55%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.62
Debt/EBITDA 6.1
Cap/Depr 68.02%
Cap/Sales 2.75%
Interest Coverage 1.35
Cash Conversion 70.34%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.75
Altman-Z 2.31
F-Score4
WACC10.51%
ROIC/WACC0.92
Cap/Depr(3y)68.95%
Cap/Depr(5y)77.05%
Cap/Sales(3y)3.55%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2125%
EPS 3Y19.79%
EPS 5Y-5.76%
EPS Q2Q%3400%
EPS Next Y128.63%
EPS Next 2Y53.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.75%
Revenue growth 3Y-17.98%
Revenue growth 5Y-8.76%
Sales Q2Q%-40.59%
Revenue Next Year-23.59%
Revenue Next 2Y-12.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.72%
EBIT growth 3Y12.77%
EBIT growth 5Y-5.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3173.4%
FCF growth 3Y10.1%
FCF growth 5Y3.72%
OCF growth 1Y79%
OCF growth 3Y-8.74%
OCF growth 5Y-3.07%